Evidence map›Paper›PMID 42360265›Full record

ArticleJACC. Case reports2026

Chagas in Children Unmasked With Multimodality Imaging.

Sannya V Hede, Deepa Prasad

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sannya V HedeDriscoll Children's Hospital, Corpus Christi, Texas, USA. Electronic address: Sannya.hede@dchstx.org.
Deepa PrasadDriscoll Children's Hospital, Corpus Christi, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChagas disease is typically acquired during childhood but evolves into chronic cardiomyopathy over decades in 30% to 40% of infected individuals. Among Latin America-born patients with newly diagnosed nonischemic cardiomyopathy in the United States, 13% to 19% have Chagas disease as the underlying etiology. CASE SUMMARY: We present 3 pediatric cases illustrating the mechanistic connection between childhood infection and lifetime cardiomyopathy risk: 1) acute myocarditis with cardiac arrest and complete recovery after early benznidazole treatment; 2) fulminant myocarditis requiring venoarterial extracorporeal membrane oxygenation with severely reduced global longitudinal strain and left ventricular apical thrombus; and 3) chronic cardiomyopathy with myocardial fibrosis on cardiac magnetic resonance and regional strain abnormalities. Speckle-tracking echocardiography and cardiac magnetic resonance revealed the mechanistic substrate for disease progression. DISCUSSION: These cases demonstrate the spectrum of pediatric Chagas cardiomyopathy from reversible acute myocarditis to established fibrosis. Speckle-tracking echocardiography and cardiac MRI revealed the mechanistic substrate for disease progression, detecting subclinical dysfunction and fibrosis that predict progression to overt cardiomyopathy. TAKE-HOME MESSAGES: Early recognition and treatment of pediatric Chagas disease prevents adult cardiomyopathy by interrupting persistent parasitemia. Speckle-tracking echocardiography and cardiac magnetic resonance detect subclinical dysfunction and fibrosis predicting disease progression.

Indexed as

cardiomyopathyechocardiographyMR sequences

Identifiers

PMID42360265
PMCPMC13464162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.